Search research articles
Contact Us
Filters
Showing results (61-70 of 115) with videos related to
Page
of 12
Sort By:
Breast Cancer Research and Treatment
|
June 30, 2006
Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients
Christian Schindlbeck, Udo Jeschke, Sandra Schulze, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 20, 2015
Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients
Sabine Heublein, Doris Mayr, Markus Egger, et al.
Neurochemical Research
|
August 8, 2008
Thrombin-induced regulation of CD95(Fas) expression in the N9 microglial cell line: evidence for involvement of proteinase-activated receptor(1) and extracellular signal-regulated kinase 1/2
Jonathan R Weinstein, Matthew Zhang, Mansur Kutlubaev, et al.
Journal of Neuroimmunology
|
August 15, 2012
The nucleotide-binding oligomerization domain-containing-2 ligand muramyl dipeptide enhances phagocytosis and intracellular killing of Escherichia coli K1 by Toll-like receptor agonists in microglial cells
Sandra Ribes, Nina Adam, Sandra Schütze, et al.
Infection and Immunity
|
May 25, 2004
Tyrosine kinase inhibition reduces inflammation in the acute stage of experimental pneumococcal meningitis
Klemens Angstwurm, Uwe-Karsten Hanisch, Tarraneh Gassemi, et al.
Cancer Immunology, Immunotherapy : CII
|
August 7, 2013
Empty liposomes induce antitumoral effects associated with macrophage responses distinct from those of the TLR1/2 agonist Pam3CSK 4 (BLP)
Simone König, Tommy Regen, Kai Dittmann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 25, 2015
TLR4-activated microglia require IFN-γ to induce severe neuronal dysfunction and death in situ
Ismini E Papageorgiou, Andrea Lewen, Lukas V Galow, et al.
Oncotarget
|
September 17, 2013
Zoledronic acid inhibits macrophage/microglia-assisted breast cancer cell invasion
Eva Rietkötter, Kerstin Menck, Annalen Bleckmann, et al.
Brain, Behavior, and Immunity
|
October 19, 2010
CD14 and TRIF govern distinct responsiveness and responses in mouse microglial TLR4 challenges by structural variants of LPS
Tommy Regen, Denise van Rossum, Jörg Scheffel, et al.
Genes, Chromosomes & Cancer
|
March 28, 2003
Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines
Susanne Seitz, Peter Wassmuth, Jens Plaschke, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 115) with videos related to
Sort By:
Page
of 12
Breast Cancer Research and Treatment
|
June 30, 2006
Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients
Christian Schindlbeck, Udo Jeschke, Sandra Schulze, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 20, 2015
Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients
Sabine Heublein, Doris Mayr, Markus Egger, et al.
Neurochemical Research
|
August 8, 2008
Thrombin-induced regulation of CD95(Fas) expression in the N9 microglial cell line: evidence for involvement of proteinase-activated receptor(1) and extracellular signal-regulated kinase 1/2
Jonathan R Weinstein, Matthew Zhang, Mansur Kutlubaev, et al.
Journal of Neuroimmunology
|
August 15, 2012
The nucleotide-binding oligomerization domain-containing-2 ligand muramyl dipeptide enhances phagocytosis and intracellular killing of Escherichia coli K1 by Toll-like receptor agonists in microglial cells
Sandra Ribes, Nina Adam, Sandra Schütze, et al.
Infection and Immunity
|
May 25, 2004
Tyrosine kinase inhibition reduces inflammation in the acute stage of experimental pneumococcal meningitis
Klemens Angstwurm, Uwe-Karsten Hanisch, Tarraneh Gassemi, et al.
Cancer Immunology, Immunotherapy : CII
|
August 7, 2013
Empty liposomes induce antitumoral effects associated with macrophage responses distinct from those of the TLR1/2 agonist Pam3CSK 4 (BLP)
Simone König, Tommy Regen, Kai Dittmann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 25, 2015
TLR4-activated microglia require IFN-γ to induce severe neuronal dysfunction and death in situ
Ismini E Papageorgiou, Andrea Lewen, Lukas V Galow, et al.
Oncotarget
|
September 17, 2013
Zoledronic acid inhibits macrophage/microglia-assisted breast cancer cell invasion
Eva Rietkötter, Kerstin Menck, Annalen Bleckmann, et al.
Brain, Behavior, and Immunity
|
October 19, 2010
CD14 and TRIF govern distinct responsiveness and responses in mouse microglial TLR4 challenges by structural variants of LPS
Tommy Regen, Denise van Rossum, Jörg Scheffel, et al.
Genes, Chromosomes & Cancer
|
March 28, 2003
Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines
Susanne Seitz, Peter Wassmuth, Jens Plaschke, et al.
Page
of 12